Vor Biopharma Inc [VOR] stock is trading at $30.22, down -1.91%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VOR shares have lost -9.52% over the last week, with a monthly amount drifted -3.76%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on October 15, 2025, when Robert W. Baird upgraded its rating to a Outperform but kept the price target unchanged to $64 for it. Previously, Stifel upgraded its rating to Buy on September 24, 2025, and kept the price target unchanged to $55. On June 30, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $3 on the stock. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $18 on July 26, 2022. Goldman initiated its recommendation with a Neutral and recommended $6 as its price target on April 27, 2022. H.C. Wainwright started tracking with a Buy rating for this stock on December 17, 2021, and assigned it a price target of $26. In a note dated December 03, 2021, Robert W. Baird initiated an Outperform rating and provided a target price of $38 on this stock.
Vor Biopharma Inc [VOR] stock has fluctuated between $2.62 and $65.80 over the past year. Currently, Wall Street analysts expect the stock to reach $40.67 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $30.22 at the most recent close of the market. An investor can expect a potential return of 34.58% based on the average VOR price forecast.
Analyzing the VOR fundamentals
Gross Profit Margin for this corporation currently stands at -0.54% with Operating Profit Margin at -99.67%, Pretax Profit Margin comes in at -451.55%, and Net Profit Margin reading is -451.55%. To continue investigating profitability, this company’s Return on Assets is posted at -8.1, Equity is 5.24 and Total Capital is -2.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Vor Biopharma Inc’s Current Ratio is 3.49. Also, the Quick Ratio is 3.49, while the Cash Ratio stands at 3.24.
Transactions by insiders
Recent insider trading involved Reprogrammed Interchange LLC, 10% Owner, that happened on Oct 10 ’25 when 40983.0 shares were sold. 10% Owner, Reprogrammed Interchange LLC completed a deal on Oct 14 ’25 to sell 33668.0 shares. Meanwhile, 10% Owner Reprogrammed Interchange LLC sold 22006.0 shares on Oct 13 ’25.
